LCBVX | VIVIX | LCBVX / VIVIX | |
Total Expense Ratio | 1.23 | 0.04 | 3,075% |
Annual Report Gross Expense Ratio | 1.23 | 0.04 | 3,075% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | -0.728 | 1.452 | -50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.27B | 184B | 1% |
Annual Yield % from dividends | 0.71 | 2.29 | 31% |
Returns for 1 year | -6.81 | 7.27 | -94% |
Returns for 3 years | 7.80 | 20.30 | 38% |
Returns for 5 years | 32.42 | 63.59 | 51% |
Returns for 10 years | 41.10 | 102.59 | 40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VALIX | 13.20 | 0.05 | +0.38% |
Value Line Capital Appreciation Investor | |||
RSIPX | 14.52 | N/A | N/A |
Columbia Disciplined Core Inst2 | |||
RYWAX | 49.65 | N/A | N/A |
Rydex S&P SmallCap 600 Pure Growth H | |||
JEMNX | 9.83 | N/A | N/A |
JHancock Emerging Markets Equity R4 | |||
GQFPX | 12.14 | N/A | N/A |
GQG Partners Global Quality Value Fd Inv |